See more : Mesa Laboratories, Inc. (MLAB) Income Statement Analysis – Financial Results
Complete financial analysis of Allergy Therapeutics plc (AGY.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allergy Therapeutics plc, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Basant Agro Tech (India) Limited (BASANTGL.BO) Income Statement Analysis – Financial Results
- NeoPharm CO., LTD. (092730.KQ) Income Statement Analysis – Financial Results
- CIE Automotive India Limited (CIEINDIA.NS) Income Statement Analysis – Financial Results
- California Business Bank (CABB) Income Statement Analysis – Financial Results
- Trans Genic Inc. (2342.T) Income Statement Analysis – Financial Results
Allergy Therapeutics plc (AGY.L)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.allergytherapeutics.com
About Allergy Therapeutics plc
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55.20M | 59.59M | 72.77M | 84.33M | 78.20M | 73.72M | 68.35M | 64.14M | 48.51M | 43.23M | 41.96M | 39.28M | 41.28M | 41.55M | 40.75M | 37.76M | 31.02M | 25.74M | 23.56M | 20.61M | 18.00M | 17.33M | 15.14M |
| Cost of Revenue | 25.46M | 26.90M | 23.81M | 22.53M | 20.69M | 18.38M | 17.01M | 16.77M | 14.07M | 12.18M | 11.95M | 11.95M | 13.67M | 13.22M | 11.16M | 13.56M | 10.87M | 10.07M | 6.51M | 4.85M | 5.51M | 5.33M | 5.27M |
| Gross Profit | 29.74M | 32.69M | 48.95M | 61.80M | 57.51M | 55.34M | 51.33M | 47.37M | 34.44M | 31.05M | 30.00M | 27.33M | 27.61M | 28.33M | 29.59M | 24.19M | 20.16M | 15.67M | 17.05M | 15.75M | 12.49M | 12.00M | 9.87M |
| Gross Profit Ratio | 53.87% | 54.86% | 67.27% | 73.28% | 73.54% | 75.07% | 75.11% | 73.85% | 71.00% | 71.83% | 71.51% | 69.57% | 66.88% | 68.18% | 72.60% | 64.08% | 64.98% | 60.89% | 72.35% | 76.45% | 69.37% | 69.26% | 65.18% |
| Research & Development | 22.90M | 20.12M | 15.66M | 12.89M | 9.00M | 6.95M | 16.02M | 9.30M | 16.22M | 3.12M | 2.96M | 2.54M | 2.10M | 1.67M | 2.21M | 5.30M | 16.30M | 25.34M | 9.56M | 5.62M | 451.00K | 527.00K | 2.54M |
| General & Administrative | 22.79M | 25.18M | 20.83M | 20.67M | 19.63M | 17.60M | 15.32M | 13.71M | 10.09M | 10.01M | 7.99M | 7.85M | 15.18M | -8.29M | -6.03M | -14.74M | -12.71M | -11.14M | -6.81M | -4.96M | -2.23M | 0.00 | 0.00 |
| Selling & Marketing | 19.59M | 23.71M | 26.00M | 25.20M | 24.85M | 27.00M | 27.13M | 26.89M | 20.22M | 17.06M | 17.92M | 16.28M | 17.88M | 17.52M | 16.14M | 14.89M | 12.85M | 11.31M | 9.83M | 8.01M | 6.57M | 0.00 | 0.00 |
| SG&A | 42.38M | 47.42M | 46.30M | 46.27M | 44.06M | 44.78M | 42.65M | 40.75M | 30.49M | 27.26M | 26.11M | 24.12M | 33.06M | 9.23M | 10.12M | 158.00K | 147.00K | 169.00K | 3.03M | 3.05M | 4.34M | 0.00 | 0.00 |
| Other Expenses | -287.00K | -856.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 699.00K | 150.00K | -191.00K | 0.00 | 0.00 | -2.10M | -196.00K | -193.00K | 3.37M | 367.00K | 31.00K | -350.00K | -262.00K | -34.00K | 13.04M | 11.53M |
| Operating Expenses | 64.99M | 67.54M | 61.96M | 59.16M | 53.06M | 51.12M | 58.25M | 49.40M | 46.52M | 30.47M | 28.94M | 26.66M | 35.16M | 28.39M | 28.01M | 32.68M | 44.71M | 50.92M | 24.80M | 18.95M | 10.93M | 13.57M | 14.07M |
| Cost & Expenses | 90.46M | 94.44M | 85.77M | 81.69M | 73.75M | 69.50M | 75.26M | 66.17M | 60.59M | 42.65M | 40.89M | 38.61M | 48.83M | 41.62M | 39.17M | 46.25M | 55.58M | 60.99M | 31.31M | 23.81M | 16.45M | 18.90M | 19.34M |
| Interest Income | 285.00K | 329.00K | 257.00K | 117.00K | 266.00K | 77.00K | 19.00K | 63.00K | 18.00K | 77.00K | 15.00K | 19.00K | 5.00K | 2.00K | 9.00K | 30.00K | 201.00K | 647.00K | 545.00K | 531.00K | 60.00K | 33.00K | 24.00K |
| Interest Expense | 4.11M | 2.16M | 541.00K | 386.00K | 339.00K | 11.00K | 122.00K | 71.00K | 122.00K | 218.00K | 308.00K | 404.00K | 457.00K | 1.54M | 1.79M | 3.24M | 1.97M | 131.00K | 4.00K | 42.00K | 26.00K | 39.00K | 545.00K |
| Depreciation & Amortization | 4.32M | 4.22M | 4.17M | 4.13M | 3.91M | 2.09M | 2.02M | 1.94M | 1.57M | 1.14M | 1.12M | 1.34M | 1.89M | 1.70M | 1.43M | 1.32M | 1.16M | 955.00K | 1.12M | 884.00K | 319.00K | 944.00K | 1.92M |
| EBITDA | -30.74M | -36.24M | -8.69M | 7.61M | 11.69M | 5.80M | -4.56M | -291.00K | -10.11M | 1.88M | 2.12M | 2.08M | 3.99M | 728.00K | 2.91M | -7.05M | -17.24M | -24.67M | -5.05M | -1.00M | 2.27M | 5.24M | -2.31M |
| EBITDA Ratio | -55.69% | -51.40% | -12.14% | 8.03% | 10.70% | 0.00% | -7.23% | -0.45% | -21.76% | 4.35% | 5.06% | 5.17% | 7.24% | 0.70% | 7.19% | -15.11% | -55.17% | -95.76% | -21.40% | -6.11% | 10.75% | 13.49% | -14.93% |
| Operating Income | -35.26M | -34.85M | -13.00M | 2.64M | 4.46M | -1.84M | -6.70M | -1.98M | -12.12M | 739.00K | 1.00M | 668.00K | 1.09M | 115.00K | 1.46M | 5.10M | 15.59M | 26.28M | 6.71M | 2.42M | 1.56M | -1.57M | 4.25M |
| Operating Income Ratio | -63.87% | -58.49% | -17.87% | 3.13% | 5.70% | -2.49% | -9.81% | -3.09% | -24.99% | 1.71% | 2.39% | 1.70% | 2.65% | 0.28% | 3.57% | 13.52% | 50.26% | 102.07% | 28.50% | 11.73% | 8.64% | -9.04% | 28.08% |
| Total Other Income/Expenses | -3.91M | -2.97M | -1.15M | -941.00K | -872.00K | -98.00K | -166.00K | -74.00K | -113.00K | -71.00K | 81.00K | -139.00K | -452.00K | -2.43M | -1.57M | -16.54M | -4.61M | 548.00K | 1.15M | -4.35M | 34.00K | 5.83M | -9.02M |
| Income Before Tax | -39.17M | -42.62M | -13.40M | 3.09M | 7.44M | 4.29M | -6.90M | -1.97M | -12.06M | 654.00K | 1.08M | 432.00K | 640.00K | -2.31M | -116.00K | -11.44M | -20.24M | -25.76M | -6.17M | -2.19M | 1.59M | 4.26M | -4.77M |
| Income Before Tax Ratio | -70.95% | -71.53% | -18.41% | 3.66% | 9.51% | 5.82% | -10.09% | -3.07% | -24.87% | 1.51% | 2.58% | 1.10% | 1.55% | -5.57% | -0.28% | -30.29% | -65.26% | -100.07% | -26.20% | -10.63% | 8.83% | 24.58% | -31.52% |
| Income Tax Expense | 1.05M | 449.00K | 379.00K | 204.00K | 379.00K | 826.00K | 637.00K | 511.00K | 1.01M | 546.00K | 343.00K | -104.00K | -183.00K | 349.00K | -702.00K | 326.00K | 53.00K | -2.50M | 217.00K | -83.00K | 372.00K | -916.00K | -109.00K |
| Net Income | -40.22M | -43.07M | -13.78M | 2.89M | 7.06M | 3.47M | -7.53M | -2.48M | -13.07M | 108.00K | 741.00K | 536.00K | 823.00K | -2.66M | 586.00K | -11.76M | -20.30M | -23.26M | -6.17M | -2.19M | 1.22M | 5.18M | -4.66M |
| Net Income Ratio | -72.86% | -72.28% | -18.93% | 3.42% | 9.03% | 4.70% | -11.02% | -3.87% | -26.95% | 0.25% | 1.77% | 1.36% | 1.99% | -6.41% | 1.44% | -31.16% | -65.43% | -90.34% | -26.20% | -10.63% | 6.77% | 29.87% | -30.80% |
| EPS | -0.01 | -0.06 | -0.02 | 0.00 | 0.01 | 0.01 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.14 | -0.25 | -0.28 | -0.09 | -0.04 | 0.03 | 0.08 | -0.07 |
| EPS Diluted | -0.01 | -0.06 | -0.02 | 0.00 | 0.01 | 0.01 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.14 | -0.25 | -0.28 | -0.09 | -0.04 | 0.03 | 0.08 | -0.07 |
| Weighted Avg Shares Out | 3.74B | 669.84M | 643.02M | 671.32M | 672.19M | 666.73M | 593.20M | 590.85M | 570.36M | 542.71M | 463.41M | 486.92M | 326.80M | 310.76M | 293.14M | 81.99M | 81.95M | 81.95M | 66.12M | 57.47M | 49.29M | 62.95M | 62.95M |
| Weighted Avg Shares Out (Dil) | 3.74B | 670.36M | 642.99M | 676.66M | 673.49M | 669.70M | 595.10M | 592.19M | 570.34M | 498.24M | 471.51M | 471.65M | 340.05M | 323.35M | 305.58M | 81.99M | 81.95M | 81.95M | 66.12M | 57.47M | 49.29M | 62.95M | 62.95M |
Source: https://incomestatements.info
Category: Stock Reports